Nicotinamide Riboside Supplementation Restores Myocardial Nicotinamide Adenine Dinucleotide Levels, Improves Survival, and Promotes Protective Environment Post Myocardial Infarction-Reference-Cited by-同舟云学术

Nicotinamide Riboside Supplementation Restores Myocardial Nicotinamide Adenine Dinucleotide Levels, Improves Survival, and Promotes Protective Environment Post Myocardial Infarction

Published:2023-11-24 Issue: Volume: Page:
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Tannous Cynthia,Ghali Rana,Karoui Ahmed,Habeichi Nada J.,Amin Ghadir,Booz George W.,Mericskay Mathias,Refaat Marwan,Zouein Fouad A.^ORCID

Funder

Faculty of Medicine, American University of Beirut

Centre National de la Recherche Scientifique

Institut pour la Recherche sur la Moelle épinière et l'Encéphale

Fondation de France

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10557-023-07525-1.pdf

Reference31 articles.

1. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–59. https://doi.org/10.1016/S0140-6736(17)32154-2.

2. Cohen M, Gensini GF, Maritz F, et al. Prospective evaluation of clinical outcomes after acute ST-elevation myocardial infarction in patients who are ineligible for reperfusion therapy: preliminary results from the TETAMI registry and randomized trial. Circulation. 2003;108(16 Suppl 1):III14-21. https://doi.org/10.1161/01.CIR.0000091832.74006.1C.

3. Eagle KA, Goodman SG, Avezum A, et al. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet. 2002;359(9304):373–7. https://doi.org/10.1016/S0140-6736(02)07595-5.

4. Srivastava S. Emerging therapeutic roles for NAD(+) metabolism in mitochondrial and age-related disorders. Clin Transl Med. 2016;5(1):25. https://doi.org/10.1186/s40169-016-0104-7.

5. Winnik S, Auwerx J, Sinclair DA, Matter CM. Protective effects of sirtuins in cardiovascular diseases: from bench to bedside. Eur Heart J. 2015;36(48):3404–12. https://doi.org/10.1093/eurheartj/ehv290.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of NAD+ in Myocardial Ischemia-induced Heart Failure in Sprague-dawley Rats and Beagles;Current Pharmaceutical Biotechnology;2024-12

2. HuMSC-EVs Protect Endothelial Cells Against Hypoxia/Reoxygenation Injury by Inhibiting the Pannexin 1/p38-MAPK Pathway;Transplantation Proceedings;2024-09

3. Emerging interactions between mitochondria and NAD+ metabolism in cardiometabolic diseases;Trends in Endocrinology & Metabolism;2024-08

4. Nicotinamide riboside attenuates myocardial ischemia-reperfusion injury via regulating SIRT3/SOD2 signaling pathway;Biomedicine & Pharmacotherapy;2024-06

5. The role of nicotinamide adenine dinucleotide salvage enzymes in cardioprotection;Polish Journal of Cardio-Thoracic Surgery;2024